Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1992 | 12-1991 | 09-1991 | 06-1991 | 03-1991 | |
| Sales | 1,557,100 | 1,572,600 | 1,341,300 | 1,376,300 | 1,435,500 |
| Cost of Goods | 435,100 | 547,700 | 392,300 | 388,200 | 389,500 |
| Gross Profit | 1,122,000 | 1,088,400 | 949,000 | 988,100 | 1,046,000 |
| Operating Expenses | 542,000 | 592,400 | 540,300 | 558,000 | 550,700 |
| Operating Income | 580,100 | 433,200 | 409,000 | 430,300 | 495,800 |
| Other Income | 56,800 | 12,300 | 16,000 | 23,200 | 59,400 |
| Pre-tax Income | 636,900 | 445,500 | 425,000 | 453,500 | 555,200 |
| Income Tax | 194,300 | 134,400 | 127,500 | 136,000 | 166,600 |
| Net Income Continuous | 444,700 | 311,100 | 297,500 | 317,500 | 388,600 |
| Net Income Discontinuous | -118,900 | 0 | 0 | 0 | 0 |
| Net Income | $325,800 | $311,100 | $297,500 | $317,500 | $388,600 |
| EPS Basic Total Ops | 0.38 | 0.27 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.38 | 0.27 | N/A | N/A | N/A |
| EPS Basic Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.28 | 0.27 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.38 | 0.27 | N/A | N/A | N/A |
| EPS Diluted Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $580,100 | $433,200 | $409,000 | $430,300 | $495,800 |